https://www.marketscreener.com/quote/stock/IRLAB-THERAPEUTICS-AB-61747292/news/IRLAB-Therapeutics-publ-Phase-IIa-study-with-IRL752-is-published-in-Movement-Disorders-30213297/?utm_source=telegram&utm_medium=social&utm_campaign=share